Response-adapted sequential azacitidine and induction chemotherapy in patients > 60 years old with newly diagnosed AML eligible for chemotherapy. Results of the DRKS00004519 study of the East German Study Group
HAEMATOLOGICA(2017)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined